Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations

Abstract The major drawback of the eye drops is rapid elimination of drug from the precorneal region, thus ensuing poor bioavailability as well as therapeutic efficacy. To conquer these limitations, a pH triggered in situ gel was developed for sustained delivery of levofloxacin. Two polymers namely hydroxypropyl methylcellulose (HPMC) and sodium alginate along with the boric acid buffer were used to formulate the in situ gel. Based on the various physicochemical evaluation parameters like pH, clarity and gelling capacity placebo formulations were selected and further characterized for viscosity, in vitro release, ex vivo corneal permeation, and histopathological studies. The optimized in situ gel (F28) showed sustained release of 93 ± 4.23% for 24 h and cumulative drug permeation of 71.81 ± 4.7% for 72 h. Additionally, ocular irritation study and histopathology of the formulation treated cornea confirm the non-irritancy of the optimized formulation. Based on all the above performed studies, it can be concluded that the in situ gel would present a fruitful alternative for the ocular infections.

[1]  W. Grimm.  Stability Testing: Photostability Testing of New Drug Substances and Products , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[2]  Himankar Baishya,et al.  Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets , 2017 .

[3]  G. Abdelbary,et al.  Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies , 2017, Drug delivery.

[4]  S. S. Imam,et al.  Levofloxacin loaded gelrite-cellulose polymer based sustained ocular drug delivery: formulation, optimization and biological study , 2016 .

[5]  A. Müllertz,et al.  Newer Trends in In Situ Gelling Systems for Controlled Ocular Drug Delivery , 2016 .

[6]  Osama Saher,et al.  Levofloxacin hemihydrate ocular semi-sponges for topical treatment of bacterial conjunctivitis: Formulation and in-vitro/in-vivo characterization , 2016 .

[7]  A. Gadad,et al.  Formulation and evaluation of sparfloxacin emulsomes-loaded thermosensitive in situ gel for ophthalmic delivery , 2016, Journal of Sol-Gel Science and Technology.

[8]  M. PuranikK,et al.  Voriconazole In situ Gel for Ocular Drug Delivery , 2015 .

[9]  S. Paliwal,et al.  Effect of In Vitro Transcorneal Approach of Aceclofenac Eye Drops through Excised Goat, Sheep, and Buffalo Corneas , 2015, TheScientificWorldJournal.

[10]  K. Pathak,et al.  Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study , 2014, Drug development and industrial pharmacy.

[11]  K. Pathak,et al.  Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: Ex-vivo transcorneal permeation, corneal toxicity and irritation testing , 2013, Drug development and industrial pharmacy.

[12]  D. Ouyang,et al.  Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. , 2013, Drug discovery today.

[13]  I. Gonjari,et al.  In situ gelling systems of ofloxacin: Comparative performance of in vivo precorneal drainage and pharmacokinetic study , 2013 .

[14]  M. Geetha,et al.  Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride , 2012, International journal of pharmaceutical investigation.

[15]  O. Afieroho,et al.  A Simple UV Spectrophotometric Method for the Determination of Levofloxacin in Dosage Formulations , 2011 .

[16]  L. Gan,et al.  Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. , 2010, International journal of pharmaceutics.

[17]  R. Ramakrishnan,et al.  Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test. , 2010, Indian journal of pathology & microbiology.

[18]  Frank A Barile,et al.  Validating and troubleshooting ocular in vitro toxicology tests. , 2010, Journal of pharmacological and toxicological methods.

[19]  A. Kampik,et al.  A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  A. Kaminska,et al.  Clinical and Microbiological Efficacy of Levofloxacin Administered three Times a Day for the Treatment of Bacterial Conjunctivitis , 2009, European journal of ophthalmology.

[21]  S. Scoper.  Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy , 2008, Advances in therapy.

[22]  Weisan Pan,et al.  Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. , 2006, International journal of pharmaceutics.

[23]  M. Aqil,et al.  Evaluation of Carbopol-Methyl Cellulose Based Sustained-Release Ocular Delivery System for Pefloxacin Mesylate Using Rabbit Eye Model , 2006, Pharmaceutical development and technology.

[24]  M. Traidej,et al.  Effectiveness of Ciprofloxacin, Levofloxacin, or Moxifloxacin for Treatment of Experimental Staphylococcus aureus Keratitis , 2004, Antimicrobial Agents and Chemotherapy.

[25]  Darlene Miller,et al.  Comparative In Vitro Activity of Levofloxacin, Ofloxacin, and Ciprofloxacin Against Ocular Streptococcal Isolates , 2004, Cornea.

[26]  W. Scheld,et al.  Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors , 2003, Emerging infectious diseases.

[27]  P. Amin,et al.  Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R D Houlsby,et al.  Antimicrobial activity of borate-buffered solutions , 1986, Antimicrobial Agents and Chemotherapy.

[29]  Anoop Narayanan,et al.  Smart In situ Gels for Glaucoma-An Overview , 2022 .